Skip to main content
News > News > Timothy Cripe, MD,PhD to present at the Onocolytic Virotherapy Summit 2016

Timothy Cripe, MD,PhD to present at the Onocolytic Virotherapy Summit 2016

Timothy Cripe, MD, PhD to present on preclinical and preliminary phase 1 clinical safety and efficacy studies of intravenously administered seprehvir, an onocolytic herpes viroimmunotherapeutic.

san-diego-summit-2016-final-agenda

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.